The latest funding includes $25m raised in a Series C round and $35m from Pfizer to develop samuraciclib, an advanced breast cancer treatment.
Read more: Carrick Therapeutics raises $60m for novel cancer treatments
The latest funding includes $25m raised in a Series C round and $35m from Pfizer to develop samuraciclib, an advanced breast cancer treatment.
Read more: Carrick Therapeutics raises $60m for novel cancer treatments
